|
G |
Alad |
aminolevulinate dehydratase |
increases metabolic processing multiple interactions increases activity |
ISO EXP |
ALAD protein results in increased metabolism of Aminolevulinic Acid ALAD gene SNP affects the reaction [ALAD protein results in increased metabolism of Aminolevulinic Acid] Aminolevulinic Acid results in increased activity of ALAD protein Bilirubin inhibits the reaction [Aminolevulinic Acid results in increased activity of ALAD protein] |
CTD |
PMID:8687997 PMID:12853123 PMID:30025905 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
decreases expression multiple interactions increases activity |
ISO EXP |
Aminolevulinic Acid results in decreased expression of ALAS1 mRNA Bilirubin inhibits the reaction [Aminolevulinic Acid results in increased activity of ALAS1 protein] |
CTD |
PMID:12853123 PMID:22859313 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Aminolevulinic Acid analog results in increased expression of BAX mRNA |
CTD |
PMID:20676910 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
Aminolevulinic Acid analog results in decreased expression of BCL2 mRNA |
CTD |
PMID:20676910 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP3 protein] |
CTD |
PMID:11281435 PMID:17245620 PMID:20426806 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
ISO |
Aminolevulinic Acid analog results in increased activity of CASP8 protein pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP8 protein] |
CTD |
PMID:21138480 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
ISO EXP |
pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] 3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] |
CTD |
PMID:17245620 PMID:20426806 PMID:21138480 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
EXP |
Aminolevulinic Acid results in decreased activity of CAT protein Bilirubin inhibits the reaction [Aminolevulinic Acid results in decreased activity of CAT protein] |
CTD |
PMID:12853123 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cs |
citrate synthase |
decreases activity |
EXP |
Aminolevulinic Acid results in decreased activity of CS protein |
CTD |
PMID:1537718 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Fadd |
Fas associated via death domain |
multiple interactions increases phosphorylation |
ISO |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Aminolevulinic Acid analog results in increased phosphorylation of FADD protein]; FADD mutant form inhibits the reaction [Aminolevulinic Acid analog results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased phosphorylation of FADD protein] |
CTD |
PMID:21138480 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fech |
ferrochelatase |
multiple interactions |
ISO |
[Aminolevulinic Acid results in decreased activity of FECH protein] which results in increased abundance of Iron |
CTD |
PMID:15078340 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases activity multiple interactions |
EXP |
Aminolevulinic Acid results in decreased activity of GPX1 protein Bilirubin inhibits the reaction [Aminolevulinic Acid results in decreased activity of GPX1 protein] |
CTD |
PMID:12853123 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression increases activity |
ISO EXP |
NFE2L2 gene mutant form promotes the reaction [Aminolevulinic Acid results in increased expression of HMOX1 mRNA] Aminolevulinic Acid results in increased activity of HMOX1 protein Bilirubin inhibits the reaction [Aminolevulinic Acid results in increased activity of HMOX1 protein]; tin protoporphyrin IX inhibits the reaction [Aminolevulinic Acid results in increased activity of HMOX1 protein] |
CTD |
PMID:12853123 PMID:22859313 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Mag |
myelin-associated glycoprotein |
decreases expression |
EXP |
Aminolevulinic Acid results in decreased expression of MAG protein |
CTD |
PMID:18665889 |
|
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases activity |
EXP |
Aminolevulinic Acid analog results in increased activity of MAPK1 protein |
CTD |
PMID:20426806 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases activity |
EXP |
Aminolevulinic Acid analog results in increased activity of MAPK3 protein |
CTD |
PMID:20426806 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
affects expression multiple interactions |
ISO |
Aminolevulinic Acid affects the expression of MMP1 mRNA; Aminolevulinic Acid affects the expression of MMP1 protein Sodium Azide inhibits the reaction [Aminolevulinic Acid affects the expression of MMP1 protein] |
CTD |
PMID:12542540 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases activity multiple interactions |
EXP |
Aminolevulinic Acid analog results in increased activity of MMP2 protein Chitosan inhibits the reaction [Aminolevulinic Acid analog results in increased activity of MMP2 protein] |
CTD |
PMID:18806744 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
affects expression multiple interactions |
ISO |
Aminolevulinic Acid affects the expression of MMP3 mRNA; Aminolevulinic Acid affects the expression of MMP3 protein Sodium Azide inhibits the reaction [Aminolevulinic Acid affects the expression of MMP3 protein] |
CTD |
PMID:12542540 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mpz |
myelin protein zero |
decreases expression |
EXP |
Aminolevulinic Acid results in decreased expression of MPZ protein |
CTD |
PMID:18665889 |
|
NCBI chr13:83,570,811...83,576,680
Ensembl chr13:83,570,811...83,576,679
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
decreases expression |
EXP |
Aminolevulinic Acid results in decreased expression of NDUFB8 protein |
CTD |
PMID:18665889 |
|
NCBI chr 1:243,408,656...243,413,715
Ensembl chr 1:243,408,619...243,413,817
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
NFE2L2 gene mutant form inhibits the reaction [Aminolevulinic Acid results in increased expression of CYP2A5 mRNA]; NFE2L2 gene mutant form promotes the reaction [Aminolevulinic Acid results in increased expression of HMOX1 mRNA] |
CTD |
PMID:22859313 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
FADD mutant form inhibits the reaction [Aminolevulinic Acid analog results in increased cleavage of PARP1 protein] |
CTD |
PMID:21138480 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pmp22 |
peripheral myelin protein 22 |
decreases expression |
EXP |
Aminolevulinic Acid results in decreased expression of PMP22 protein |
CTD |
PMID:18665889 |
|
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
increases activity |
EXP |
Aminolevulinic Acid analog results in increased activity of PRKAA1 protein |
CTD |
PMID:20426806 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects localization |
ISO |
Aminolevulinic Acid analog affects the localization of RELA protein |
CTD |
PMID:21138480 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases activity multiple interactions |
EXP |
Aminolevulinic Acid results in decreased activity of SOD1 protein Bilirubin inhibits the reaction [Aminolevulinic Acid results in decreased activity of SOD1 protein] |
CTD |
PMID:12853123 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases activity |
EXP |
Aminolevulinic Acid results in decreased activity of SOD2 protein |
CTD |
PMID:1537718 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
Aminolevulinic Acid analog results in increased expression of TP53 |
CTD |
PMID:17311614 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Urod |
uroporphyrinogen decarboxylase |
decreases activity multiple interactions |
ISO |
Aminolevulinic Acid results in decreased activity of UROD protein Hexachlorobenzene promotes the reaction [Aminolevulinic Acid results in decreased activity of UROD protein] |
CTD |
PMID:8937451 |
|
NCBI chr 5:130,464,695...130,468,783
Ensembl chr 5:130,455,217...130,468,808
|
|